P63 Patient-Reported Outcomes Following Treatment with Vimseltinib for Tenosynovial Giant Cell Tumour in a Phase 2 Expansion Study

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.075
https://www.valueinhealthjournal.com/article/S1098-3015(22)02277-X/fulltext
Title : P63 Patient-Reported Outcomes Following Treatment with Vimseltinib for Tenosynovial Giant Cell Tumour in a Phase 2 Expansion Study
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02277-X&doi=10.1016/j.jval.2022.09.075
First page :
Section Title :
Open access? : No
Section Order : 10261
Categories :
Tags :
Regions :
ViH Article Tags :